Smeets, Nori J. L. http://orcid.org/0000-0002-4927-2459
Teunissen, Esther M. M.
van der Velden, Kim
van der Burgh, Maurice J. P.
Linders, Demi E.
Teesselink, Elodie
Moes, Dirk-Jan A. R.
Tøndel, Camilla
ter Heine, Rob
van Heijst, Arno
Schreuder, Michiel F.
de Wildt, Saskia N.
Article History
Received: 31 March 2022
Revised: 11 May 2022
Accepted: 1 June 2022
First Online: 2 August 2022
Declarations
:
: The Iohexol for Measuring Renal Function (HERO) study was conducted in accordance with the principles of Good Clinical Practice. Details of this study were registered in advance on ClinicalTrials.gov on May 10, 2019 (registration number NCT03946345). The HERO study protocol was approved by the local medical ethics review board (CMO Arnhem-Nijmegen, NL68547.091.18, 2018–5025).
: Not applicable.
: The authors declare no competing interests.